17.93MMarket Cap
LossP/E TTM
Key Figures
0.715Open
0.720High
80.00KVolume
LossP/E TTM
--P/E Dynamic
--Dividend TTM
0.28%Turnover Ratio
0.680Prev. Close
0.601Low
44.37KTurnover
LossP/E Static
-0.89P/B
0.00%Div Yield TTM
-76.43%ROA
4.35052wk High
1.11Volume Ratio
-57.89MNet Profit
28.22MShares
-3.5861EPS TTM
0.47Beta
-6372.60%ROE
0.71052wk Low
17.50%Amplitude
-88.86%Gross Margin
17.93MMarket Cap
1.76Reward/Risk
5.52%Risk Rate
Currency: USD Updated: 2026-07-31 Key Insights
Celularity Inc's fundamentals are relatively stable, and its growth potential is significant.Its valuation is considered fairly valued, ranking 121 out of 155 in the Pharmaceuticals industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as , with the highest price target at 6.00.In the medium term, the stock price is expected to trend down.Despite a very weak stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Celularity Inc Highlights
StrengthsRisks
Celularity Inc News
More news coming soon, stay tuned...
Earnings Forecast
Strong Buy
Buy
Hold
Sell
Strong Sell
Indicators
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Celularity Inc Info
Celularity Inc. is a regenerative and cellular medicine company. The Company is developing and commercializing advanced biomaterial products and allogeneic, cryopreserved, placental-derived cell therapies, all derived from the postpartum placenta. Its therapeutic programs target aging-related diseases, including degenerative diseases, cancer, and immune disorders, using mesenchymal-like adherent stromal cells, T-cells engineered with CAR (CAR T-cells), and genetically modified and unmodified natural killer (NK) cells. It develops, manufactures and commercializes advanced biomaterial products derived from structural tissue components of the postpartum placental tissues, including the umbilical cord. Its advanced biomaterials include Celularity Tendon Wrap, FUSE Bone Void Filler and Celularity Placental Matrix. Its advanced biomaterial products include Biovance, Biovance 3L, CentaFlex, Interfyl and Rebound products.
Ticker SymbolCELU
CompanyCelularity Inc
CEOHariri (Robert J)
Websitehttps://celularity.com/
Shareholders
FAQs
What is the current price of Celularity Inc (CELU)?
The current price of Celularity Inc (CELU) is 0.64.
What is the symbol of Celularity Inc?
The ticker symbol of Celularity Inc is CELU.
What is the 52-week high of Celularity Inc?
The 52-week high of Celularity Inc is 4.35.
What is the 52-week low of Celularity Inc?
The 52-week low of Celularity Inc is 0.71.
What is the market capitalization of Celularity Inc?
The market capitalization of Celularity Inc is 17.93M.
What is the Earnings Per Share (EPS TTM) of Celularity Inc (CELU)?
The Earnings Per Share (EPS TTM) of Celularity Inc (CELU) is -3.59.
